Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TIVICAY PD
- Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
- The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
- Inflammation and Co-Infections in D²EFT
- Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults
- Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.
- ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence
- A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers
- ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy
- Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir
- The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers
- Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
- Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019
- National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection
- Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
- Dolutegravir in Reservoirs
- Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet
- Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
- Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients
- Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
- Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients
- Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet
- Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen
- A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 La
- Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity
- Dual Therapy With Boosted Darunavir + Dolutegravir
- The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial
- Renal Integrase Study
- Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)
- Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients
- Antiretroviral Therapy for Acute and Chronic HIV Infection
- Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Clinical trials list
click for details